Hawrysz Stephen

Avg. Two Year Performance

(36%) Avg. Purchase Return
(16%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(2%)(4%)14%3%(36%)
Purchase Success Rate0 of 10 of 11 of 11 of 10 of 1
Average Sale Return13%15%27%27%0%
Sale Success Rate1 of 11 of 11 of 11 of 10 of 1
Drugs » Biotechnology

Chief Financial Officer:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--